Research Articles | Page 99 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab Dec 2020 European Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium Dec 2020 Cancer Medicine myelodysplastic syndromes (MDS)
Current and emerging strategies for management of myelodysplastic syndromes Dec 2020 Blood reviews myelodysplastic syndromes (MDS)
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Jan 2021 Journal of clinical oncology: official journal of the American Society Clinical Oncology myelodysplastic syndromes (MDS)
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse Jan 2021 Clinical Lymphoma , Myeloma & Leukemia myelodysplastic syndromes (MDS)
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia Jan 2021 Seminars in Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) Jan 2021 Cancer Causes & Control : CCC myelodysplastic syndromes (MDS)
Share with addtoany.com.